发明名称 |
PHARMACEUTICAL COMPOSITION USING ALISKIREN AND AVOSENTAN |
摘要 |
The present invention relates to a pharmaceutical composition and method of achieving a therapeutic effect including, but not limited to, the treatment of hypertension, kidney or heart disease in an animal, preferably a mammal including a human subject, using (i) SPP100/aliskiren or a pharmaceutically acceptable salt thereof in combination with (ii) SPP301/avosentan or a pharmaceutically acceptable salt thereof and (iii) a pharmaceutically acceptable carrier.
|
申请公布号 |
US2010173919(A1) |
申请公布日期 |
2010.07.08 |
申请号 |
US20070448467 |
申请日期 |
2007.12.21 |
申请人 |
SCHUMACHER CHRISTOPH;HUXLEY ALICE;ZAUGG CHRISTIAN;BALTATU OVIDIU |
发明人 |
SCHUMACHER CHRISTOPH;HUXLEY ALICE;ZAUGG CHRISTIAN;BALTATU OVIDIU |
分类号 |
A61K31/513;A61P9/00;A61P9/12;A61P13/12 |
主分类号 |
A61K31/513 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|